<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations/><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/C514A3A9-E140-4888-AFB2-5814D127FD79"><gtr:id>C514A3A9-E140-4888-AFB2-5814D127FD79</gtr:id><gtr:name>MRC Centre Cambridge</gtr:name><gtr:department>LMB Structural Studies</gtr:department><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 0QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/C514A3A9-E140-4888-AFB2-5814D127FD79"><gtr:id>C514A3A9-E140-4888-AFB2-5814D127FD79</gtr:id><gtr:name>MRC Centre Cambridge</gtr:name><gtr:address><gtr:line1>Hills Road</gtr:line1><gtr:line4>Cambridge</gtr:line4><gtr:postCode>CB2 0QH</gtr:postCode><gtr:region>East of England</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/72A73B18-2D53-451A-9ED2-EB5BB7E83050"><gtr:id>72A73B18-2D53-451A-9ED2-EB5BB7E83050</gtr:id><gtr:firstName>Christopher</gtr:firstName><gtr:otherNames>G</gtr:otherNames><gtr:surname>Tate</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=BB%2FG003653%2F1"><gtr:id>18E8CA4D-C513-49B8-A0DB-F1F0294FFE29</gtr:id><gtr:title>Folding and stability of the beta adrenergic receptor</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>BB/G003653/1</gtr:grantReference><gtr:abstractText>Proteins are the 'worker molecules' in life. Cells in our bodies sense and communicate with the outside world via proteins embedded in membranes that surround the cells. This project aims to design a new method to study a particular type of protein, membrane proteins. In particular, it is focussed on a protein that acts as a receptor during communication between cells. This receptor is a member of the largest family of membrane proteins in the human genome, a family that is the major target for the development of new medicines. Unfortunately, there is a limited understanding of how these membrane receptor proteins work at a molecular level. This is because they are notoriously unstable outside the membrane and it is difficult to obtain sufficient amounts for scientific study. Recent advances are, however, beginning to alter this situation. We aim to devise new methods to study a phenomenon known as 'folding'. Genes carry the code for proteins, but puzzles remain in deciphering how genetic information is translated into functional proteins. Proteins begin as a string of amino acids, which then have to fold-up to a particular shape in the right part of the body. If this folding fails, disaster strikes and the proteins malfunction. The most glaring gaps in knowledge of this folding phenomenon come with membrane proteins. We propose to forge new territory by devising new methods to understand membrane protein folding. We intend to work out what makes the receptor unstable and investigate how to ensure it folds correctly.</gtr:abstractText><gtr:technicalSummary>G protein coupled receptors are the largest family of membrane proteins in the human genome and dominate targets for the development of new drugs. A major challenge in biomolecular research of receptors is to fold and stabilise the proteins. We propose to study the denaturation process and devise methods to re-fold and stabilise the beta adrenergic receptor. Research into G protein coupled receptors is at an exciting stage, with the recent determination of high resolution structures of a human beta adrenergic receptor. Moreover, we and our collaborators have stabilised another beta adrenergic receptor through mutagenesis and solved the structure. This thermostable mutant receptor has tremendous potential in a folding study as the increased stability and reduced conformational heterogeneity greatly improve the chances of successful refolding. Refolding becomes an even better prospect in the lipid bicelle system we will use. We have shown that bicelles dramatically improve the stability of a G protein coupled receptor and they are a highly successful refolding system for helical membrane proteins in general. Moreover, bicelles were used to obtain crystals of the beta receptor. A tactic we will employ with the bicelles is to alter the properties off their lipid bilayer-disc to favour activated conformations of the beta adrenergic receptor. We will use our experience in devising lipid folding systems to create bicelle environments that stabilise and fold different conformations of the receptor. Different mutants will also allow us to probe the role of particular structural regions during denaturation, unfolding and refolding. We believe GPCR folding is a tractable problem. The employment of bicelles and mutants that stabilise the receptor, together with knowledge of the denaturation mechanism, affords a very good opportunity to identify key receptor structural losses and prevent or reverse them.</gtr:technicalSummary><gtr:fund><gtr:end>2013-03-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/2512EF1C-401B-4222-9869-A770D4C5FAC7"><gtr:id>2512EF1C-401B-4222-9869-A770D4C5FAC7</gtr:id><gtr:name>BBSRC</gtr:name></gtr:funder><gtr:start>2009-04-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>359503</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs/><gtr:disseminationOutputs/><gtr:exploitationOutputs/><gtr:furtherFundingOutputs/><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:keyFindingsOutput><gtr:description>We have determined multiple structures of a G protein coupled receptor that leads to an understanding of how the receptor changes its conformation from an inactive to active state.</gtr:description><gtr:exploitationPathways>Drug discovery to improve efficacy of beta blockers or drugs fro the treatment of asthma</gtr:exploitationPathways><gtr:id>B44F55C5-A0A4-42D6-985B-4B06FEFF140D</gtr:id><gtr:outcomeId>54525545c40c29.66497256</gtr:outcomeId><gtr:sectors><gtr:sector>Pharmaceuticals and Medical Biotechnology</gtr:sector></gtr:sectors></gtr:keyFindingsOutput><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>D36D19FA-FAAD-48F7-AFF8-B64ED37BD690</gtr:id><gtr:title>Complete Reversible Refolding of a G-Protein Coupled Receptor on a Solid Support.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/169a19052ba9fe7b9e6ca4b2b6d8945a"><gtr:id>169a19052ba9fe7b9e6ca4b2b6d8945a</gtr:id><gtr:otherNames>Di Bartolo N</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>589b4bd9eefb62.02448893</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0AA018E7-BC2B-41E6-A3B8-F10C40A1C45C</gtr:id><gtr:title>Agonist-bound structures of G protein-coupled receptors.</gtr:title><gtr:parentPublicationTitle>Current opinion in structural biology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43425f1acf151f249bff6c720fcdec2f"><gtr:id>43425f1acf151f249bff6c720fcdec2f</gtr:id><gtr:otherNames>Lebon G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-440X</gtr:issn><gtr:outcomeId>doi_55f94b94b778ecde</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0ACE2901-6BB7-459B-AAA3-8A3BE6563755</gtr:id><gtr:title>The 2.1 &amp;Aring; resolution structure of cyanopindolol-bound ?1-adrenoceptor identifies an intramembrane Na+ ion that stabilises the ligand-free receptor.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42fc964e9a17cb4aa4a27503281402ed"><gtr:id>42fc964e9a17cb4aa4a27503281402ed</gtr:id><gtr:otherNames>Miller-Gallacher JL</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>54490fed04ff72.88844420</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7DF56AEF-F2CC-48B2-BD40-985D28C2D95E</gtr:id><gtr:title>Two distinct conformations of helix 6 observed in antagonist-bound structures of a beta1-adrenergic receptor.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f325ee2468867aaaec862512de7aa85c"><gtr:id>f325ee2468867aaaec862512de7aa85c</gtr:id><gtr:otherNames>Moukhametzianov R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>C198E5UXSG6</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>EF9B77D5-F2E6-4437-A910-D7EC5939596B</gtr:id><gtr:title>The importance of interactions with helix 5 in determining the efficacy of ?-adrenoceptor ligands.</gtr:title><gtr:parentPublicationTitle>Biochemical Society transactions</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16e358d7ed8ed9d826b3972c81abba6b"><gtr:id>16e358d7ed8ed9d826b3972c81abba6b</gtr:id><gtr:otherNames>Warne T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0300-5127</gtr:issn><gtr:outcomeId>doi_12623_ST20120228</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>74EFE0A9-0CEB-420A-A60A-4E225222367B</gtr:id><gtr:title>A crystal clear solution for determining G-protein-coupled receptor structures.</gtr:title><gtr:parentPublicationTitle>Trends in biochemical sciences</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a3d1bb467c9a9b6b1af4649dc5d94ea9"><gtr:id>a3d1bb467c9a9b6b1af4649dc5d94ea9</gtr:id><gtr:otherNames>Tate CG</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0968-0004</gtr:issn><gtr:outcomeId>doi_55f94b94b782baf5</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0896582B-097C-41CD-B2D3-72795E41403B</gtr:id><gtr:title>Agonist-bound adenosine A2A receptor structures reveal common features of GPCR activation.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/43425f1acf151f249bff6c720fcdec2f"><gtr:id>43425f1acf151f249bff6c720fcdec2f</gtr:id><gtr:otherNames>Lebon G</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>fZ65hKtNspP</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A53C564B-4D06-4A9F-81DC-12ECE36939F4</gtr:id><gtr:title>Crystal structures of a stabilized ?1-adrenoceptor bound to the biased agonists bucindolol and carvedilol.</gtr:title><gtr:parentPublicationTitle>Structure (London, England : 1993)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16e358d7ed8ed9d826b3972c81abba6b"><gtr:id>16e358d7ed8ed9d826b3972c81abba6b</gtr:id><gtr:otherNames>Warne T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0969-2126</gtr:issn><gtr:outcomeId>pm_12623_23_22579251</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BAD8A80D-09DC-4737-BC8F-F7A377866831</gtr:id><gtr:title>The structural basis for agonist and partial agonist action on a ?(1)-adrenergic receptor.</gtr:title><gtr:parentPublicationTitle>Nature</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/16e358d7ed8ed9d826b3972c81abba6b"><gtr:id>16e358d7ed8ed9d826b3972c81abba6b</gtr:id><gtr:otherNames>Warne T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-0836</gtr:issn><gtr:outcomeId>A1F28DB4_9A1F28DB4_9</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>67CF5EE6-8F75-43E5-A9D8-E82527C30CF2</gtr:id><gtr:title>Biophysical fragment screening of the ?1-adrenergic receptor: identification of high affinity arylpiperazine leads using structure-based drug design.</gtr:title><gtr:parentPublicationTitle>Journal of medicinal chemistry</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/a4b12b32ed65eea701e03ef917a41098"><gtr:id>a4b12b32ed65eea701e03ef917a41098</gtr:id><gtr:otherNames>Christopher JA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>0022-2623</gtr:issn><gtr:outcomeId>doi_55f94b94b78f0efa</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">BB/G003653/1</gtr:identifier></gtr:identifiers><gtr:healthCategories/><gtr:researchActivities/><gtr:researchSubjects/><gtr:researchTopics><gtr:researchTopic><gtr:id>D05BC2E0-0345-4A3F-8C3F-775BC42A0819</gtr:id><gtr:text>Unclassified</gtr:text></gtr:researchTopic></gtr:researchTopics><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>